171 related articles for article (PubMed ID: 28423583)
1. The protection of meloxicam against chronic aluminium overload-induced liver injury in rats.
Yang Y; He Q; Wang H; Hu X; Luo Y; Liang G; Kuang S; Mai S; Ma J; Tian X; Chen Q; Yang J
Oncotarget; 2017 Apr; 8(14):23448-23458. PubMed ID: 28423583
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 Signalling Pathway in the Cortex is Involved in the Pathophysiological Mechanisms in the Rat Model of Depression.
Chen Q; Luo Y; Kuang S; Yang Y; Tian X; Ma J; Mai S; Xue L; Yang J
Sci Rep; 2017 Mar; 7(1):488. PubMed ID: 28352129
[TBL] [Abstract][Full Text] [Related]
3. Antifibrotic effect of meloxicam in rat liver: role of nuclear factor kappa B, proinflammatory cytokines, and oxidative stress.
Hassan MH; Ghobara MM
Naunyn Schmiedebergs Arch Pharmacol; 2016 Sep; 389(9):971-83. PubMed ID: 27245167
[TBL] [Abstract][Full Text] [Related]
4. Meloxicam Improves Cognitive Impairment of Diabetic Rats through COX2-PGE2-EPs-cAMP/pPKA Pathway.
Li H; Luo Y; Xu Y; Yang L; Hu C; Chen Q; Yang Y; Ma J; Zhang J; Xia H; Li Y; Yang J
Mol Pharm; 2018 Sep; 15(9):4121-4131. PubMed ID: 30109938
[TBL] [Abstract][Full Text] [Related]
5. cAMP/PKA-CREB-BDNF signaling pathway in hippocampus mediates cyclooxygenase 2-induced learning/memory deficits of rats subjected to chronic unpredictable mild stress.
Luo Y; Kuang S; Li H; Ran D; Yang J
Oncotarget; 2017 May; 8(22):35558-35572. PubMed ID: 28415673
[TBL] [Abstract][Full Text] [Related]
6. Meloxicam modulates oxidative stress status, inhibits prostaglandin E2, and abrogates apoptosis in carbon tetrachloride-induced rat hepatic injury.
Edfawy M; Hassan MH; Mansour A; Hamed AA; Amin HA
Int J Toxicol; 2012 Jun; 31(3):276-86. PubMed ID: 22556387
[TBL] [Abstract][Full Text] [Related]
7. Treatment with either COX-2 inhibitor or 5-LOX inhibitor causes no compensation between COX-2 pathway and 5-LOX pathway in chronic aluminum overload-induced liver injury in rats.
Xia H; He Q; Wang H; Wang Y; Yang Y; Li Y; Zhang J; Chen Z; Yang J
Fundam Clin Pharmacol; 2019 Oct; 33(5):535-543. PubMed ID: 30903708
[TBL] [Abstract][Full Text] [Related]
8. Hippocampal neuronal metal ion imbalance related oxidative stress in a rat model of chronic aluminum exposure and neuroprotection of meloxicam.
Yu L; Jiang R; Su Q; Yu H; Yang J
Behav Brain Funct; 2014 Mar; 10():6. PubMed ID: 24618126
[TBL] [Abstract][Full Text] [Related]
9. Hippocampal neuronal cyclooxygenase-2 downstream signaling imbalance in a rat model of chronic aluminium gluconate administration.
Wang H; Ye M; Yu L; Wang J; Guo Y; Lei W; Yang J
Behav Brain Funct; 2015 Feb; 11():8. PubMed ID: 25888969
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of meloxicam on aluminum overload-induced cerebral damage in mice.
Jun-Qing Y; Bei-Zhong L; Bai-Cheng H; Qi-Qin Z
Eur J Pharmacol; 2006 Oct; 547(1-3):52-8. PubMed ID: 16928369
[TBL] [Abstract][Full Text] [Related]
11. 5-lipoxygenase activation is involved in the mechanisms of chronic hepatic injury in a rat model of chronic aluminum overload exposure.
Mai S; He Q; Wang H; Hu X; Luo Y; Yang Y; Kuang S; Tian X; Ma J; Yang J
Toxicol Appl Pharmacol; 2016 Aug; 305():259-266. PubMed ID: 27368151
[TBL] [Abstract][Full Text] [Related]
12. Beraprost sodium protects against chronic brain injury in aluminum-overload rats.
Pan Y; Yu L; Lei W; Guo Y; Wang J; Yu H; Tang Y; Yang J
Behav Brain Funct; 2015 Feb; 11(1):6. PubMed ID: 25888780
[TBL] [Abstract][Full Text] [Related]
13. Effects of food intake and oxidative stress on intestinal lesions caused by meloxicam and piroxicam in rats.
Villegas I; Alarcón de la Lastra C; La Casa C; Motilva V; Martín MJ
Eur J Pharmacol; 2001 Feb; 414(1):79-86. PubMed ID: 11230998
[TBL] [Abstract][Full Text] [Related]
14. Misoprostol Reverse Hippocampal Neuron Cyclooxygenase-2 Downstream Signaling Imbalance in Aluminum-Overload Rats.
Guo Y; Lei W; Wang J; Hu X; Wei Y; Ji C; Yang J
Curr Alzheimer Res; 2016; 13(9):1006-16. PubMed ID: 27033056
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of dexketoprofen trometamol, meloxicam and diclofenac sodium on fibular fracture healing, kidney and liver: an experimental rat model.
Inal S; Kabay S; Cayci MK; Kuru HI; Altikat S; Akkas G; Deger A
Injury; 2014 Mar; 45(3):494-500. PubMed ID: 24246878
[TBL] [Abstract][Full Text] [Related]
16. Oxysophocarpine Ameliorates Carrageenan-induced Inflammatory Pain via Inhibiting Expressions of Prostaglandin E2 and Cytokines in Mice.
Yang Y; Li YX; Wang HL; Jin SJ; Zhou R; Qiao HQ; Du J; Wu J; Zhao CJ; Niu Y; Sun T; Yu JQ
Planta Med; 2015 Jul; 81(10):791-7. PubMed ID: 26132856
[TBL] [Abstract][Full Text] [Related]
17. Ketoconazole suppresses prostaglandin E(2)-induced cyclooxygenase-2 expression in human epidermoid carcinoma A-431 cells.
Kanda N; Watanabe S
J Invest Dermatol; 2002 Jul; 119(1):174-81. PubMed ID: 12164941
[TBL] [Abstract][Full Text] [Related]
18. Effects of an ophthalmic formulation of meloxicam on COX-2 expression, PGE2 release, and cytokine expression in a model of acute ocular inflammation.
Cruz R; Quintana-Hau JD; González JR; Tornero-Montaño R; Baiza-Durán LM; Vega L
Br J Ophthalmol; 2008 Jan; 92(1):120-5. PubMed ID: 17962388
[TBL] [Abstract][Full Text] [Related]
19. Effects of nonsteroidal anti-inflammatory meloxicam on stomach, kidney, and liver of rats.
Burukoglu D; Baycu C; Taplamacioglu F; Sahin E; Bektur E
Toxicol Ind Health; 2016 Jun; 32(6):980-6. PubMed ID: 24958741
[TBL] [Abstract][Full Text] [Related]
20. Modulatory effects of meloxicam on cardiotoxicity and antitumor activity of doxorubicin in mice.
Hassan MH; El-Beshbishy HA; Aly H; Attia SM; Bahashwan SA; Ghobara MM
Cancer Chemother Pharmacol; 2014 Sep; 74(3):559-69. PubMed ID: 25053391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
